Autoimmune Cytopenia as an Early and Initial Presenting Manifestation in Activated PI3 Kinase Delta Syndrome: Case Report and Review
暂无分享,去创建一个
Benjamin D. Smith | S. Gold | Steven M. Johnson | S. Schworer | Andrew B Smitherman | E. Wu | O. Francis
[1] A. Durandy,et al. Increased activation of PI3 kinase-δ predisposes to B cell lymphoma. , 2020, Blood.
[2] Kelli W. Williams,et al. Hematopoietic Stem Cell Transplantation for Progressive Combined Immunodeficiency and Lymphoproliferation in Patients With Activated Phosphatidylinositol–3–OH Kinase δ Syndrome Type 1 , 2019, Pediatrics.
[3] J. Bussel,et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. , 2019, Blood advances.
[4] J. Cannons,et al. T and B‐cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity , 2019, Immunological reviews.
[5] L. Notarangelo,et al. Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells. , 2019, The Journal of allergy and clinical immunology.
[6] F. Aghamahdi,et al. Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review , 2019, Clinical Reviews in Allergy & Immunology.
[7] S. Rosenzweig,et al. PI3K pathway defects leading to immunodeficiency and immune dysregulation , 2019, The Journal of allergy and clinical immunology.
[8] S. Tangye,et al. Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD—the Goldilocks’ Effect , 2019, Journal of Clinical Immunology.
[9] L. Notarangelo. Hematopoietic stem cell transplantation for activated phosphoinositide 3-kinase δ syndrome: Who, when, and how? , 2019, The Journal of allergy and clinical immunology.
[10] S. Choo,et al. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity , 2019, The Journal of allergy and clinical immunology.
[11] A. Cant,et al. The Treatment of Activated PI3Kδ Syndrome , 2018, Front. Immunol..
[12] G. Uzel,et al. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8+ T Cell Survival, Differentiation, and Function , 2018, Front. Immunol..
[13] J. Orange,et al. Use of Genetic Testing for Primary Immunodeficiency Patients , 2018, Journal of Clinical Immunology.
[14] A. Fischer,et al. Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry , 2018, Front. Immunol..
[15] B. Sloth,et al. Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib. , 2017, Blood.
[16] Lewis C. Cantley,et al. The PI3K Pathway in Human Disease , 2017, Cell.
[17] F. Alt,et al. Phosphatidylinositol 3-Kinase (PI3K) δ blockade increases genomic instability in B cells , 2017, Nature.
[18] Bodo Grimbacher,et al. Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study , 2017, The Journal of allergy and clinical immunology.
[19] C. Cunningham-Rundles,et al. Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry , 2017, Journal of Clinical Immunology.
[20] K. Okkenhaug,et al. PI3Kδ and primary immunodeficiencies , 2016, Nature Reviews Immunology.
[21] T. Molina,et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study. , 2016, The Journal of allergy and clinical immunology.
[22] B. Lambrecht,et al. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? , 2016, Journal of Medical Genetics.
[23] B. Fevang,et al. Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency , 2016, Clinical and experimental immunology.
[24] R. Naik. Warm autoimmune hemolytic anemia. , 2015, Hematology/oncology clinics of North America.
[25] Roger L. Williams,et al. Synergy in activating class I PI3Ks. , 2015, Trends in biochemical sciences.
[26] J. Hughes,et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K , 2014, The Journal of experimental medicine.
[27] J. B. Oliveira,et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency , 2013, Nature Immunology.
[28] Nada Jabado,et al. Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage , 2013, Science.
[29] R. Abraham,et al. Autoimmune Cytopenias In Common Variable Immunodeficiency , 2012, Front. Immun..
[30] Drew Provan,et al. International consensus report on the investigation and management of primary immune thrombocytopenia. , 2010, Blood.